China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a significant drop in short interest during the month of September. As of September 30th, there was short interest totaling 145,300 shares, a drop of 54.0% from the September 15th total of 316,200 shares. Based on an average daily trading volume, of 306,100 shares, the days-to-cover ratio is currently 0.5 days. Based on an average daily trading volume, of 306,100 shares, the days-to-cover ratio is currently 0.5 days.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of China SXT Pharmaceuticals in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of China SXT Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Saturday, August 2nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, China SXT Pharmaceuticals currently has an average rating of “Sell”.

China SXT Pharmaceuticals Stock Performance

China SXT Pharmaceuticals stock opened at $1.42 on Wednesday. China SXT Pharmaceuticals has a 52 week low of $0.95 and a 52 week high of $7.84. The company’s 50 day moving average price is $1.60 and its two-hundred day moving average price is $1.73. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.54 and a quick ratio of 3.40.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.